Oral sodium hyaluronate relieves knee discomfort: A 12‑week double‑blinded, placebo‑controlled study

Sugiyama,Kiichi; Oe,Mariko; Tanaka,Tomomi; Matsuoka,Ryosuke; Takeda,Yumi; Kimura,Mamoru; Odani,Koji

doi:10.3892/etm.2023.12352

Oral sodium hyaluronate relieves knee discomfort: A 12‑week double‑blinded, placebo‑controlled study

Authors:
- Kiichi Sugiyama
- Mariko Oe
- Tomomi Tanaka
- Ryosuke Matsuoka
- Yumi Takeda
- Mamoru Kimura
- Koji Odani
View Affiliations

Affiliations: Personal Coaching Laboratory, Hokkaido University of Education, Iwamizawa, Hokkaido 068‑0835, Japan, Research and Development Division, Kewpie Corporation, Tokyo 182‑0002, Japan, Sapporo Columbia Medical Office, Sapporo, Hokkaido 060‑0001, Japan
Published online on: December 15, 2023 https://doi.org/10.3892/etm.2023.12352
Article Number: 64
Copyright : © Sugiyama et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Sodium hyaluronate (SH) is a high molecular‑weight polysaccharide composed of repeating polymeric disaccharides of D‑glucuronic acid and N‑acetyl‑D‑glucosamine. SH is present in every connective tissue and organ, with synovial fluid having the highest concentration of SH in the body. The effectiveness of oral SH on gonarthrosis is known; although, its influence on the knees of healthy individuals is not. However, as severe diseases may require surgery, it is better to take care of healthy knees before the onset of gonarthrosis. Therefore, the present study investigated the functionality of SH on the knee of healthy individuals. The present study was a randomized double‑blind, placebo‑controlled trial in which healthy adults (mean age: Placebo group, 61.50±1.59; SH group, 58.50±1.81), rated as grade ≤1 based on the Kellgren‑Lawrence classification, were administered 111 mg/day SH for 12 weeks. The evaluation of visual analog scales were performed to assess the discomfort in the knees of the participants and were conducted at baseline, and then 6 and 12 weeks after the start of SH ingestion. Additionally, a locomotive syndrome risk test quantifying the mobility of the participants, a one‑leg standing time with eyes open test evaluating the strength of the leg muscle as well as the ability to balance by measuring the time to stand on one leg and a blood test (interleukin‑10, aspartate aminotransferase, alanine transaminase, γ‑glutamyl transferase, lactate dehydrogenase, creatine kinase and C‑reactive protein) were performed at baseline and then 12 weeks after the start of SH ingestion. A significant suppression of knee symptoms were demonstrated in the SH group compared with the placebo group in terms of the total visual analog scale scores for pain, stiffness and discomfort for the 31 healthy adult subjects. Significant suppression of symptoms was also demonstrated in the placebo group in terms of discomfort in the knees when descending stairs and pain in the knees after walking for a longer distance or duration than normal. No significant differences between the two groups were demonstrated in the locomotive syndrome risk test, one‑leg standing time with eyes open test and the blood test. The results of the present study suggest the possibility that oral SH may help to maintain a healthy condition of the knees. The study protocol was registered with the University Hospital Medical Information Network Clinical Trial Registry in advance (registration no. UMIN000045980, November 4, 2021).

View Figures

View References

1	GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: A systematic analysis for the global burden of disease study 2019. Lancet. 396:1204–1222. 2019.PubMed/NCBI View Article : Google Scholar
2	Hunter DJ and Bierma-Zeinstra S: Osteoarthritis. Lancet. 393:1745–1759. 2019.PubMed/NCBI View Article : Google Scholar
3	Centers for Disease Control and Prevention (CDC). Prevalence of arthritis-United States, 1997. MMWR Morb Mortal Wkly Rep. 50:334–336. 2001.PubMed/NCBI
4	Loeser RF Jr: Aging and the etiopathogenesis and treatment of osteoarthritis. Rheum Dis Clin North Am. 26:547–567. 2000.PubMed/NCBI View Article : Google Scholar
5	Peyron JG and Balazs EA: Preliminary clinical assessment of Na-hyaluronate injection into human arthritic joints. Pathol Biol (Paris). 22:731–736. 1974.PubMed/NCBI
6	Kilincoglu V, Yeter A, Servet E, Kangal M and Yildirim M: Short term results comparison of intraarticular platelet-rich plasma (prp) and hyaluronic acid (ha) applications in early stage of knee osteoarthritis. Int J Clin Exp Med. 8:18807–18812. 2015.PubMed/NCBI
7	Øiestad BE, Juhl CB, Culvenor AG, Berg B and Thorlund JB: Knee extensor muscle weakness is a risk factor for the development of knee osteoarthritis: An updated systematic review and meta-analysis including 46 819 men and women. Br J Sports Med. 56:349–355. 2022.PubMed/NCBI View Article : Google Scholar
8	Wei N and Dai Z: The role of nutrition in osteoarthritis: A literature review. Clin Geriatr Med. 38:303–322. 2022.PubMed/NCBI View Article : Google Scholar
9	Brophy RH and Fillingham YA: aaos clinical practice guideline summary: Management of osteoarthritis of the knee (Nonarthroplasty), third edition. J Am Acad Orthop Surg. 30:e721–e729. 2022.PubMed/NCBI View Article : Google Scholar
10	Tanaka T: Questionnaire survey on marathon life of civil runner. Tokushima University Bulletin. 22:19–34. 2013.(In Japanese).
11	Castillo B, Sepúlveda F and Micheo W: Conservative management and rehabilitation in the older runner with knee osteoarthritis: An evidence-based review. Am J Phys Med Rehabil. 98:416–421. 2019.PubMed/NCBI View Article : Google Scholar
12	Shipway R and Holloway I: Health and the running body: Notes from an ethnography. Int Rev Sociol Sport. 51:78–96. 2016.
13	Fraser JR, Laurent TC and Laurent UB: Hyaluronan: Its nature, distribution, functions and turnover. J Intern Med. 242:27–33. 1997.PubMed/NCBI View Article : Google Scholar
14	Balazs EA, Watson D, Duff IF and Roseman S: Hyaluronic acid in synovial fluid. I. Molecular parameters of hyaluronic acid in normal and arthritic human fluids. Arthritis Rheum. 10:357–376. 1967.PubMed/NCBI View Article : Google Scholar
15	Ogura M, Takabe W, Yagi M, Wakayama S and Yonei Y: Study for investigation of symptomatic improvement and safety of the ingestion of rooster comb degradation product containing low-molecular hyaluronic acid (INJUV) in individuals with knee and lower back pain; open label trial with no control group. Glycative Stress Res. 5:55–67. 2018.
16	Sato T and Iwaso H: An effectiveness study of hyaluronic acid Hyabest^® (J) in the treatment of osteoarthritis of the knee on the patients in the United State. J New Rem Clin. 58:551–558. 2009.
17	Möller I, Martinez-Puig D and Chetrit C: LB012 oral administration of a natural extract rich in hyaluronic acid for the treatment of knee OA with synovitis: A retrospective cohort study. Clin Nutr Suppl. 4:171–172. 2009.
18	Yoshimura M, Aoba Y, Watari T, Momomura R, Watanabe K, Tomonaga A, Matsunaga M, Suda Y, Lee WY, Asai K, et al: Evaluation of the effect of a chicken comb extract-containing supplement on cartilage and bone metabolism in athletes. Exp Ther Med. 4:577–580. 2012.PubMed/NCBI View Article : Google Scholar
19	Martinez-Puig D, Möller I, Fernández C and Chetrit C: Efficacy of oral administration of yoghurt supplemented with a preparation containing hyaluronic acid (Mobilee™) in adults with mild joint discomfort: A randomized, double-blind, placebo-controlled intervention study. Mediterr J Nutr Metab. 6:63–68. 2013.
20	Nelson FR, Zvirbulis RA, Zonca B, Li KW, Turner SM, Pasierb M, Wilton P, Martinez-Puig D and Wu W: The effects of an oral preparation containing hyaluronic acid (Oralvisc^®) on obese knee osteoarthritis patients determined by pain, function, bradykinin, leptin, inflammatory cytokines, and heavy water analyses. Rheumatol Int. 35:43–52. 2015.PubMed/NCBI View Article : Google Scholar
21	Jensen GS, Attridge VL, Lenninger MR and Benson KF: Oral intake of a liquid high-molecular-weight hyaluronan associated with relief of chronic pain and reduced use of pain medication: Results of a randomized, placebo-controlled double-blind pilot study. J Med Food. 18:95–101. 2015.PubMed/NCBI View Article : Google Scholar
22	Kohn MD, Sassoon AA and Fernando ND: Classifications in brief: Kellgren-Lawrence classification of osteoarthritis. Clin Orthop Relat Res. 474:1886–1893. 2016.PubMed/NCBI View Article : Google Scholar
23	Tashiro T, Seino S, Sato T, Matsuoka R, Masuda Y and Fukui N: Oral administration of polymer hyaluronic acid alleviates symptoms of knee osteoarthritis: A double-blind, placebo-controlled study over a 12-month period. ScientificWorldJournal. 2012(167928)2012.PubMed/NCBI View Article : Google Scholar
24	Sato T: Human nutrition lecture series: Introduction to randomized clinical trials part 4: Methods of randomization. Jpn J Nutr Diet. 65:255–260. 2007.(In Japanese).
25	Oe M, Tashiro T, Yoshida H, Nishiyama H, Masuda Y, Maruyama K, Koikeda T, Maruya R and Fukui N: Oral hyaluronan relieves knee pain: A review. Nutr J. 15(11)2016.PubMed/NCBI View Article : Google Scholar
26	Muranaga S and Hirano K: Development of a convenient way to predict ability to walk, using a two-step test. J Showa Med Assoc. 63:301–308. 2003.(In Japanese).
27	Muranaga S: Evaluation of the muscular strength of the lower extremities using the standing movement and clinical application. J Showa Med Assoc. 61:362–367. 2001.(In Japanese).
28	Seichi A, Hoshino Y, Doi T, Akai M, Tobimatsu Y and Iwaya T: Development of a screening tool for risk of locomotive syndrome in the elderly: The 25-question geriatric locomotive function scale. J Orthop Sci. 17:163–172. 2012.PubMed/NCBI View Article : Google Scholar
29	Yamada K, Ito YM, Akagi M, Chosa E, Fuji T, Hirano K, Ikeda S, Ishibashi H, Ishibashi Y, Ishijima M, et al: Reference values for the locomotive syndrome risk test quantifying mobility of 8681 adults aged 20-89 years: A cross-sectional nationwide study in Japan. J Orthop Sci. 25:1084–1092. 2020.PubMed/NCBI View Article : Google Scholar
30	Murata S, Oyama M, Otao H, Murata J, Toyota K, Fujino H, Yumioka M and Takeda I: Relationship between one-leg standing time with eyes open and physical function among community-dwelling elderly females. Rigakuryoho Kagaku. 23:79–83. 2008.(In Japanese).
31	Ethical guidelines for Medical and Health Research Involving Human Subjects: Ministry of Education, Culture, Sports, Science and Technology; Ministry of Health, Labor and Welfare; and Ministry of Economy, Trade and Industry, Japan, 2015.
32	Takamizawa N, Shioya N, Nagaoka H and Uchino T: Effects and safety of a dietary supplement containing hyaluronic acid derived from chicken combs on knee pain, stiffness and discomfort-A randomized, double-blind, placebo-controlled, parallel-group comparison study. Jpn Pharmacol Ther. 44:207–217. 2016.(In Japanese).
33	Akai M, Doi T, Fujino K, Iwaya T, Kurosawa H and Nasu T: An outcome measure for Japanese people with knee osteoarthritis. J Rheumatol. 32:1524–1532. 2005.PubMed/NCBI
34	Bellamy N, Buchanan WW, Goldsmith CH, Campbell J and Stitt LW: Validation study of WOMAC: A health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol. 15:1833–1840. 1988.PubMed/NCBI
35	Hatayama T, Nagano M, Yamaguchi N, Kumagai S and Oonuki K: The effect of a supplement on knee pain and discomfort evaluated by visual analogue scale (VAS): A randomized, double-blind, placebo-controlled study. Jpn J Health Promot. 10:13–17. 2008.(In Japanese).
36	Watanabe H, Urabe K, Kamiya K, Hamazaki N, Miida K, Suda K, Hendona T, Fujita M, Aikawa J, Itoman M, et al: Relationship between quality of life using the Japan knee osteoarthritis measure (JKOM) and physical function in patients with osteoarthritis of the knee. Jpn Phys Ther Assoc. 34:67–73. 2007.(In Japanese).
37	Tanabe Y and Mizukami M: Lower limb biomechanics during stair descent are related to the descent velocity of healthy young individuals. J Phys Ther Sci. 30:207–212. 2015.
38	Bagge E, Bjelle A, Eden S and Svanborg A: Osteroarthritis in elderly: Clinical and radio-logical findings in 79 and 85 years olds. Ann Rheum Dis. 50:535–539. 1991.PubMed/NCBI View Article : Google Scholar
39	Asari A, Kanemitsu T and Kurihara H: Oral administration of high molecular weight hyaluronan (900 kDa) controls immune system via toll-like receptor 4 in the intestinal epithelium. J Biol Chem. 285:24751–24758. 2010.PubMed/NCBI View Article : Google Scholar
40	Kimura M: Absorption of orally administered hyaluronan. J Funct Foods. 14:30–35. 2018.(In Japanese).
41	Taylor BD, Darville T, Ferrell RE, Ness RB and Haggerty CL: Racial variation in toll-like receptor variants among women with pelvic inflammatory disease. J Infect Dis. 207:940–946. 2013.PubMed/NCBI View Article : Google Scholar
42	Ostojic SM, Arsic M, Prodanovic S, Vukovic J and Zlatanovic M: Glucosamine administration in athletes: Effects on recovery of acute knee injury. Res Sports Med. 15:113–24. 2007.PubMed/NCBI View Article : Google Scholar
43	Sugino T, Fujita M, Sugawara Y and Kajimoto O: Pig-derived chondroitin sulfate attenuates mild knee joint pain in healthy middle and old aged people-a randomized, double-blind, placebo-controlled, parallel-group comparison trial-. JPT. 47:2045–2058. 2019.
44	Iwaso H and Sato T: Examination of the efficacy and safety of oraladministration of Hyabest^® (J)-highly-pure hyaluronic acid for knee joint pain. J Jpn Soc Clin Sports Med. 58:566–572. 2009.(In Japanese).
45	Martin JA and Buckwalter JA: Roles of articular cartilage aging and chondrocyte senescence in the pathogenesis of osteoarthritis. Iowa Orthop J. 21:1–7. 2001.PubMed/NCBI
46	Okamoto A: Hyaluronic acid and joint fluid. B&R. 13:14–23. 1999.(In Japanese).
47	Miura H: The merits and demerits of sports in osteoarthritis of the knee. Jpn J Phys Fit Sports Med. 67:168–174. 2018.(In Japanese).
48	Goto M, Hosako Y, Katayama M and Yamada T: Biochemical analysis of rheumatoid synovial fluid after serial intra-articular injection of high molecular weight sodium hyaluronate. Int J Clin Pharmacol Res. 13:161–166. 1993.PubMed/NCBI